InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-33.0%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by YOUNG JAMES F, Director. Officer active across 1 company, notably NOVAVAX INC. Aggregated, 13 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €809k. History available since 31 December 2021. The latest transaction was disclosed on 24 December 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
4,600 shares@ US$8.483.8% of flowCommon StockSEC:0001593968-25-000010:0
7,500 shares@ US$14.0910.1% of flowCommon StockSEC:0001593968-24-000910:0
6,393 shares@ US$13.628.3% of flowCommon StockSEC:0001593968-24-000881:0
6,670 shares0Common StockSEC:0001593968-24-000858:0
4,600 sharesCommon StockSEC:0001209191-23-036763:0
1,400 sharesCommon StockSEC:0001209191-22-038597:0
8,945 shares@ US$73.28670.040% mcap77.7% of flowCommon StockSEC:0001209191-22-022544:0
3,750 shares@ US$25.608.7% of flowCommon StockSEC:0001209191-22-000955
3,750 shares@ US$25.600.0057% mcap11.1% of flowCommon StockSEC:0001209191-22-000955:0
10,000 sharesCommon StockSEC:0001209191-21-045561:0
10,000 sharesCommon StockSEC:0001209191-21-045561
7,590 sharesCommon StockSEC:0001209191-21-043695
7,590 sharesCommon StockSEC:0001209191-21-043695:0
13 of 13 declarations
About YOUNG JAMES F
James F. Young is a Board Member at Novavax Inc. In this role, he contributes to the governance of the company by bringing his expertise in the biopharmaceutical sector. James plays a key role in evaluating the company's performance and overseeing growth strategies. His industry experience is a valuable asset to Novavax's management team.
